CASP1 and obesity disorder: Indeed, genetic ablation of NLRP3 or caspase-1 prevents obesity-induced adipocyte hypertrophy [19,107], yet whether this is due to changes in adipogenesis, lipolysis and/or energy metabolism remains to be further clarified.